Effects of erythropoietin on gonadotropin responses to gonadotropin-releasing hormone in uremic patients

Nephron

Volumn 77, Issue 2, 1997, Pages 169-175

  Díez, Juan J ^a   Iglesias, Pedro ^a   Bajo, María A ^b   De Alvaro, Fernando ^b   Selgas, Rafael ^b  

^a Departments of Endocrinology   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Erythropoietin; Follicle stimulating hormone; Gonadotropin releasing hormone; Luteinizing hormone; Peritoneal dialysis

Indexed keywords

ERYTHROPOIETIN; FOLLITROPIN; GONADORELIN; GONADOTROPIN; LUTEINIZING HORMONE; RECOMBINANT ERYTHROPOIETIN; TESTOSTERONE;

ADULT; ANEMIA; AREA UNDER THE CURVE; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FOLLITROPIN BLOOD LEVEL; GONADOTROPIN RELEASE; HEMODIALYSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LONG TERM CARE; LUTEINIZING HORMONE BLOOD LEVEL; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TESTOSTERONE BLOOD LEVEL; UREMIA;

EID: 0030882578     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000190269     Document Type: Article

References (46)

1. Chen JC, Vidt DG, Zorn EM, Hallberg MC, Wieland RG: Pituitary-Lcydig cell function in uremic males, J Clin Endocrinol Metab 1970: 31:14-17.
2. Feldman HA, Singer I: Endocrinology and metabolism in uremia and dialysis: A clinical review, Medicine (Baltimore) 1974:54:345-376.
3. Holdsworth S, Atkins RC, De Krctser DM: The pituitary testicular axis in men with chronic renal failure, N Engl J Med 1977:269:1245-1249.
4. Dalla Rosa C, Cascone C, Antonucci F, Mas-trogiacomo I, Forcsta C: Hypothalamic-hypo-physeal-gonadal axis in patients undergoing chronic hemodialysis, Kidney Int 1977:12:80-81.
5. Lim VS, Auletta F, Kathpalia S: Gonadal dysfunction in chronic renal failure: An cndocrino-logic review, Dial Transplant 1978:7:896-907.
6. Mooradian A, Morley J: Endocrine dysfunction in chronic renal failure, Arch Intern Med 1978:144:351-353.
7. Handclsman DJ: Hvpothalamic-pituitary-go-nadal dysfunction in renal failure, dialysis and renal transplantation, Endocr Rev 1985:6: 181-182.
8. Foulks CJ, Cushncr HM: Sexual dysfunction in the male dialysis patient: Pathogenesis, evaluation and therapy, Am J Kidney Dis 1986:8: 211-222.
9. Lim VS, Fang VS: Gonadal dysfunction in uremic men: A study of the hypothalamic-pituitary-testicular axis before and after renal transplantation, Am.I Med 1975:58:655-662.
10. Ramirez G, Bittle PA, Sanders H, Bereu BB: Hypothalamo-hypophyseal thyroid and gonadal function before and after erythropoietin therapy in dialysis patients, J Clin Endocrinol Metab 1992;74:517-524.
11. Schalch DS, Gonzälez-Barcena D, Kastin AJ, Landa L, Lee LA, Zamora MT, Schally AV: Plasma gonadotropins after administration of LH-releasing hormone in patients with renal and hepatic failure, J Clin Endocrinol Metab 1975:41:921-925.
12. Hasegawa K, Matsushita Y, Hirai K, Otomo S, Tcrvo O, Morii H, Wada M: Abnormal response of luteinizing hormone, follicle stimulating hormone, and testosterone to luteinizing hormone-releasing hormone in chronic renal failure, Acta Endocrinol (Copenh) 1978:87: 467-475.
13. Le Roith D, Danovitz G, Trestian S, Spitz IM: Dissociation of pituitary glycoprotein response to releasing hormones in chronic renal failure, Acta Endocrinol (Copenh) 1980:93:277-282.
14. Distiller LA, Morley JE, Sagel J, Pokroy M, Rabkin R: Pituitary-gonadal function in chronic renal failure: The effect of luteinizing hormone-releasing hormone and the influence of dialysis, Metabolism 1975:24:711-720.
15. Rodger RSC, Morrison I, Dewar JH, Wilkinson R, Ward MK, Kerr DNA: Loss of pulsatile luteinising hormone secretion in men with chronic renal failure, Br Med J 1985:291: 1598-1600.
16. Wheatley T, Clark PMS, Clark JDA, Raggatt PR, Evans DB, Holder R: Pulsatilily of luteinising hormone in men with chronic renal failure: Abnormal rather than absent, Br Med J 1987;294:482.
17. Talbot JA, Rodger RS, Robertson WR: Pulsatile biocactive luteinizing hormone secretion in men with chronic renal failure and following renal transplantation, Nephron 1990:56:66-72.
18. Veldhuis JD, Wilkowski MJ, Zwart D, Urban RJ, Lizarralde G, Iranmanesh A, Bolton WK: Evidence for attenuation of hypothalamic gonadotropin-releasing hormone (GnRll) impulse strength with preservation of GnRH pulse frequency in men with chronic renal failure, J Clin Endocrinol Metab 1993:76:648-654.
19. Kokot F, Wiccek A, Grzeszczak W, Klin M: Erythropoietin treatment influences follicle-stimulating hormone and luteinising hormone response to luteinising hormone-releasing hormone and plasma testosterone levels in haemo-dialysis patients, Nephrol Dial Transplant 1989:4:475.
20. Kokot F, Wieeezk A, Grzeszczak W, Klepacka J, Klin M, Lao M: Influence of erythropoietin treatment on endocrine abnormalities in hae-modialyzed patients: in Baldamus CA, Kwh KM, Scigalla P, Wieczoreck L (eds): Erythropoietin: From Molecular Structure to Clinical Application, Contrib Nephrol, Basel, Karger, 1990, vol 76, pp 257-272.
21. Kokot F, Wiecek A, Grzeszczak W, Klin M: Influence of erythropoietin treatment on folli-tropin and lulropin response to Iuliberin and plasma testosterone levels in hacmodialyzcd patients, Nephron 1990:56:126-129.
22. Kokot F, Wiecek A, Schmidt-Gavk H, Marcin-kowski W, Gilge U, Heidland A, Rudda R, Trcmbecki J: Function of endocrine organs in hemodialyzed patients on long-term erythropoietin therapy, Artif Organs 1995:19:428-435.
23. Schaefer RM, Kokot F, Kiimer B, Zech M, Heidland A: Normalization of elevated prolactin levels in hemodialysis patients on erythropoietin, Nephron 1988;50:400-401.
24. Schaefer RM, Kokot F, Heidland A: Normalization of prolactin levels and improved sexual function in dialysis patients on erythropoietin, Nephrol Dial Transplant 1988,3:501-508.
25. Schaefer RM, Kokot F, Wemze H, Geiger H, Heidland A: Improved sexual function in hae-modialysis patients on recombinant erythropoietin: A possible role for prolactin, Clin Nephrol 1989:31:1-5.
26. Schaefer RM, Hörl WH, Massry SG: Treatment of renal anemia with recombinant human erythropoietin, Am J Nephrol 1989:9:353-362.
27. Bommer J, Kugel M, Schwöbel B, Ritz E, Barth HP, Seeling R: Improved sexual function during recombinant human erythropoietin therapy, Nephrol Dial Transplant 1990:5:204-207.
28. Sundal E, Kaeser U: Correction of anaemia of chronic renal failure with recombinant human erythropoietin: Safety and efficacy of one year's treatment in a European multicentre study of 150 haemodialysis-dependent patients, Nephrol Dial Transplant 1989:4:979-987.
29. Bommer J, Elxion C, Müller-Bühl U, Eifert J, Ritz E: Recombinant human erythropoietin therapy in hacmodialysis patients: Dose determination and clinical experience, Nephrol Dial Transplant 1987;2:238-242.
30. Nisscnson AR: Recombinant human erythropoietin: Impact on brain and cognitive function, exercise tolerance, sexual potency, and quality of life, Semin Nephrol 1989;9:25-31.
31. Cantalamessa I, Cremagnani L, Orsatti A, Vigna L, Buccianti G: Increased growth hormone response to growth hormone releasing hormone induced by erythropoietin in uraemic patients, Clin Endocrinol (Oxf) 1991:34:85-89.
32. Diez JJ, Iglesias PL, Sastre J, Gómez-Pan A, Selgas R, Martínez-Ara J, Miguel JL., Mendez J: Influence of erythropoietin on paradoxical responses of growth hormone to thyrotropin-releasing hormone in uremic patients, Kidney Int 1994:46:1387-1391.
33. Ramírez G, Bittle PA, Sanders H, Rabb HAA, Bereu BB: The effects of corticotropin and growth hormone releasing hormones on their respective secretory axes in chronic hemodialysis patients before and after correction of anemia with recombinant human erythropoietin, J Clin Endocrinol Mctab 1994:78:63-69.
34. Lim VS, Kathpalia SC, Henriquez C: Endocrine abnormalities associated w ith chronic renal failure, Med Clin North Am 1978:62:1341-1361.
35. Martin-Malo A, Benito P, Castillo D, Espinosa M, Burdiel LG, Pérez R, Aljama P: Effect of clomiphene citrate on hormonal profile in male hemodialysis and kidney transplant patients, Nephron 1993;63:390-394.
36. Semplc CG, Beastallc GH, Henderson IS, Thomson JA, Kennedy AC: The pituitary-testicular axis of uraemic subjects on haemodialv-sis and continuous ambulatory peritoneal dialysis, Acta Endocrinol (Copenh) 1982:101:464-467.
37. Lim VS: Reproductive function in patients with renal insufficiency, Am J Kidney Dis 1987:9:363-367.
38. Gomez F, De la Cueva R, Wauters JP, Lemar-chand-Beraud T: Endocrine abnormalities in patients undergoing long-term hemodialysis: The role of prolactin, Am J Med 1980:68:522-530.
39. Bommer J, del Pozo E, Ritz E, Bommer G: Improved sexual function in male hemodialysis patients on bromocriptine, Lancet 1979;2: 496-497.
40. Cremagnani L, Cantalamessa L, Orsatti A, Vi-gna L, Vallino F, Buccianti G: Recombinant human erythropoietin (rhEPO) treatment potentiates growth hormone (GH) response to growth hormone release hormone (GHRH) stimulation in hemodialysis patients, Clin Nephrol 1993:39:282-286.
41. Diez JJ, Sastrc J, Igiesias P, Selgas R, Romero JR, Mendez J, Gmez-Pan A: Growth hormone responses to pituitary and hypothalamic stimuli in CAPD patients treated with recombinant human erythropoietin, Adv Pcrit Dial 1992:8:340-345.
42. Diez JJ, Igiesias P, Sastrc J, Gmez-Pan A, Mendez J, Bajo MA, Selgas R: Growth hormone and cortisol secretion before and after erythropoietin therapy in CAPD patients, Adv PeritDial 1994:10:275-281.
43. Pettersson F., Barani P, Bergstrom J: Nutritional assessment of haemodialysis patients treated with human recombinant erythropoietin, Nephrol Dial Transplant 1989:4:478.
44. Forcsta C, Mioni R, Bordon P, Miotto D, Mon-tini G, Varotto A: Erythropoietin stimulates testosterone production in man, J Clin Endocrinol Mctab 1994:78:753-756.
45. Mioni R, Gottardcllo F, Bordon P, Montini G, Forcsta C: Evidence for specific binding and stimulatory' effects of recombinant human erythropoietin on isolated adult rat Leydig cells, Acta Endocrinol (Copenh) 1992:127: 459-465.
46. Forcsta C, Mioni R, Bordon P, Gottardello F, Nogara A, Rossato M: Erythropoietin and testicular steroidogenesis: The role of second messengers, Eur J Endocrinol 1995:132:103-108.